373 related articles for article (PubMed ID: 35543828)
1. Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies.
Ali A; Ara A; Kashyap MK
Mol Biol Rep; 2022 Aug; 49(8):8087-8107. PubMed ID: 35543828
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
Singh D; Khan MA; Siddique HR
Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
[TBL] [Abstract][Full Text] [Related]
3. The microbiome and gynaecological cancer development, prevention and therapy.
Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
[TBL] [Abstract][Full Text] [Related]
5. A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation.
Di Stefano M; Santonocito S; Polizzi A; Mauceri R; Troiano G; Lo Giudice A; Romano A; Mascitti M; Isola G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674600
[TBL] [Abstract][Full Text] [Related]
6. Exploring the complex role of gut microbiome in the development of precision medicine strategies for targeting microbial imbalance-induced colon cancer.
Pal P; Shastry RP
Folia Microbiol (Praha); 2023 Oct; 68(5):691-701. PubMed ID: 37624549
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
[TBL] [Abstract][Full Text] [Related]
8. Role of the gut microbiota in tumorigenesis and treatment.
Liu Q; Yang Y; Pan M; Yang F; Yu Y; Qian Z
Theranostics; 2024; 14(6):2304-2328. PubMed ID: 38646653
[TBL] [Abstract][Full Text] [Related]
9. Next-generation probiotics: a promising approach towards designing personalized medicine.
Singh TP; Natraj BH
Crit Rev Microbiol; 2021 Aug; 47(4):479-498. PubMed ID: 33822669
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
Kang Y; Pan W; Cai Y
Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
[TBL] [Abstract][Full Text] [Related]
12. Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).
Kumavath R; Pavithran H; Paul S; Anju VT; Busi S; Dyavaiah M
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997816
[TBL] [Abstract][Full Text] [Related]
13. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
Dahiya D; Nigam PS
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
[TBL] [Abstract][Full Text] [Related]
14. The role of the microbiome in cancer development and therapy.
Bhatt AP; Redinbo MR; Bultman SJ
CA Cancer J Clin; 2017 Jul; 67(4):326-344. PubMed ID: 28481406
[TBL] [Abstract][Full Text] [Related]
15. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
17. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
18. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
19. Microbiome as a Target for Cancer Therapy.
Suraya R; Nagano T; Kobayashi K; Nishimura Y
Integr Cancer Ther; 2020; 19():1534735420920721. PubMed ID: 32564632
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiota in Celiac Disease and probiotics.
Chibbar R; Dieleman LA
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
